InnovAge Appoints Michael Scarbrough as New President and Chief Operating Officer and Maria Lozzano as President, Pharmacy Services

Published on November 4, 2024

DENVER, Nov. 04, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), appoints Michael Scarbrough as

Continue reading on website
Other news

Abzena’s advanced drug development showcased at CPHI Milan

November 1, 2024
At CPHI Milan 2024, Abzena showcased its latest innovations in cell line development and ADC manufacturing, featuring the advanced AbZelectPRO™ platform and ThioBridge™ linker technology.By offering comprehensive, integrated solutions, Abzena aims to streamline drug development processes and minimize risks for customers, helping to accelerate timelines and enhance production. Outsourcing Pharma (O

The importance of GMP in ensuring the Quality and Safety of Complex Therapeutics

November 4, 2024
In World Pharma Today, Troy Wright, Senior Vice President and Head of Quality at Abzena, discusses the vital role of Good Manufacturing Practices (GMPs) in Abzena’s operations and how they play a role in delivering high-quality, safe products throughout the drug development lifecycle.Good Manufacturing Practices (GMPs) are foundational in ensuring Quality and Safety in the biopharmaceutical indust